SCHEMBL2750558

SCHEMBL2750558

O=c1ccn(-c2ccc(C(F)(F)F)cc2)nc1-c1ccnn1-c1ccnc2ccc(F)cc12

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 6/20 0.63
UBE2N P61088 1/20 0.43
ALDH1A1 P00352 1/20 0.41
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
IDO1 P14902 1/20 0.37
TDO2 P48775 1/20 0.37
CASR P41180 1/20 0.36
SRC P12931 1/20 0.35
BRAF P15056 1/20 0.35
KDR P35968 1/20 0.35
KDM4E B2RXH2 2/20 0.35
NPSR1 Q6W5P4 1/20 0.35
SCN9A Q15858 1/20 0.34
KMT2A Q03164 2/20 0.33
PKM P14618 1/20 0.33
MEN1 O00255 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2543663 0.90 PDE10A (0.58) PDE10AUBE2NALDH1A1CYP1A2CYP3A4
SCHEMBL2545605 0.89 PDE10A (0.70) PDE10AALDH1A1CYP1A2CYP3A4CYP2C9
SCHEMBL2748982 0.88 PDE10A (0.65) PDE10AALDH1A1CYP1A2CYP3A4CYP2C9
SCHEMBL2499202 0.85 PDE10A (0.61) PDE10AALDH1A1CYP1A2CYP3A4CYP2C9
SCHEMBL3503820 0.84 PDE10A (0.61) PDE10AUBE2NALDH1A1CYP1A2CYP3A4
SCHEMBL3507656 0.84 PDE10A (0.61) PDE10A
SCHEMBL3504662 0.83 PDE10A (0.63) PDE10AALDH1A1CYP1A2CYP3A4CYP2C9
SCHEMBL2502159 0.83 PDE10A (0.68) PDE10AALDH1A1CYP1A2CYP3A4CYP2C9
SCHEMBL7913101 0.83 PDE10A (0.59) PDE10AALDH1A1CYP1A2CYP3A4CYP2C9
SCHEMBL3505194 0.83 PDE10A (0.59) PDE10AUBE2NCYP2C9IDO1TDO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8178538-B2 Pyridazinones HOFFMANN-LA ROCHE INC. (US) 2012-05-15 US disclosed
US-20100152193-A1 PYRIDAZINONES HOFFMANN-LA ROCHE, INC. 2010-06-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100152193-A1 PYRIDAZINONES PDE5A, PDE3A, PDE10A PDE10A 3/4885UBE2N 4518/4885ALDH1A1 251/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.